Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000550
Filing Date
2023-03-31
Accepted
2023-03-31 16:02:10
Documents
56
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K hhla-20221231x10k.htm   iXBRL 10-K 1614860
2 EX-4.5 hhla-20221231xex4d5.htm EX-4.5 131445
3 EX-31.1 hhla-20221231xex31d1.htm EX-31.1 16006
4 EX-31.2 hhla-20221231xex31d2.htm EX-31.2 15841
5 EX-32.1 hhla-20221231xex32d1.htm EX-32.1 6585
6 EX-32.2 hhla-20221231xex32d2.htm EX-32.2 6639
  Complete submission text file 0001410578-23-000550.txt   6032941

Data Files

Seq Description Document Type Size
7 EX-101.SCH hhla-20221231.xsd EX-101.SCH 53731
8 EX-101.CAL hhla-20221231_cal.xml EX-101.CAL 24792
9 EX-101.DEF hhla-20221231_def.xml EX-101.DEF 236643
10 EX-101.LAB hhla-20221231_lab.xml EX-101.LAB 406725
11 EX-101.PRE hhla-20221231_pre.xml EX-101.PRE 327463
50 EXTRACTED XBRL INSTANCE DOCUMENT hhla-20221231x10k_htm.xml XML 719043
Mailing Address C/O SAPPHIRE QI LI, ONE EXCHANGE SQUARE 8 CONNAUGHT PLACE SUITE 3508 CENTRAL K3 00000
Business Address C/O SAPPHIRE QI LI, ONE EXCHANGE SQUARE 8 CONNAUGHT PLACE SUITE 3508 CENTRAL K3 00000 852 6679 6578
HH&L Acquisition Co. (Filer) CIK: 0001824185 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40006 | Film No.: 23787414
SIC: 8071 Services-Medical Laboratories